Oxazepam

DRUG7 trials

Sponsors

Laboratorios Lesvi S.L., National Institute of Allergy and Infectious Diseases (NIAID), Embera NeuroTherapeutics, Inc., Catholic University of the Sacred Heart, Boehringer Ingelheim

Conditions

Alcohol DependenceAlcohol Withdrawal SyndromeAnxiety DisordersCocaine AddictionCocaine DependenceDementiaDepressionHIV Infections

Phase 1

The Pharmacokinetics of Zidovudine and Oxazepam Alone and in Combination in the HIV-Infected Patient

CompletedNCT00000661

National Institute of Allergy and Infectious Diseases (NIAID)HIV Infections

Target: 8Updated: 2008-08-04

Study to Evaluate the Presence of a Hangover Effect in Healthy Adults After Administration of Songha® Night Tablets

CompletedNCT02273453

Boehringer IngelheimHealthy

Start: 2003-02-28Updated: 2014-10-24

Comparative Bioavailability and Bioequivalence of Oxazepam 10 mg Orodispersible Tablets (Test) Versus Seresta® 10 mg Tablets (Reference): A Single-Dose, Open-Label, Randomized, Two-Sequence, Two-Treatment, Two-Period Crossover Study in Healthy Subjects

CompletedCTIS2022-501134-35-00

Laboratorios Lesvi S.L.No medical condition is being investigated. This is a comparative bioavailabilty study.

Start: 2022-10-26End: 2022-11-13Target: 28Updated: 2022-10-24

Comparative Bioavailability and Bioequivalence of Oxazepam 50 mg Orodispersible Tablets (Test) Versus Seresta® 50 mg Tablets (Reference): A Single-Dose, Open-Label, Randomized, Two-Sequence, Two-Treatment, Two-Period Crossover Study in Healthy Subjects

CompletedCTIS2022-501135-16-00

Laboratorios Lesvi S.L.No medical condition is being investigated. This is a comparative bioavailability study.

Start: 2022-12-26End: 2023-01-27Target: 28Updated: 2022-10-25

Phase 3

Pharmacovigilance in Gerontopsychiatric Patients

TerminatedNCT02374567

Hannover Medical SchoolAnxiety Disorders, Dementia, Depression +2

Start: 2015-01-31End: 2017-06-28Updated: 2018-02-28

Phase 4

Comparative Study of Gamma-hydroxy Butyrate Versus Oxazepam in the Treatment of Alcohol Withdrawal Syndrome

CompletedNCT02090504

Catholic University of the Sacred HeartAlcohol Dependence, Alcohol Withdrawal Syndrome

Start: 2002-02-28End: 2009-05-31Updated: 2014-03-18

Unknown Phase

A Placebo-Controlled Study of a Combination of Metyrapone and Oxazepam in Cocaine Addiction

CompletedNCT00567814

Embera NeuroTherapeutics, Inc.Cocaine Addiction, Cocaine Dependence

Start: 2007-12-31End: 2008-11-30Target: 45Updated: 2008-12-31

Related Papers

Sodium oxybate in the treatment of alcohol withdrawal syndrome: a randomized double-blind comparative study versus oxazepam. The GATE 1 trial.

2014-08-0123 citations